157 related articles for article (PubMed ID: 28424436)
1. [Dyslipidemia and cardiovascular risk assessment in HIV-positive patients].
Uysal S; Tuncel Başoğlu M; Boydak B; Gökengin D
Turk Kardiyol Dern Ars; 2017 Mar; 45(2):145-152. PubMed ID: 28424436
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
Padmapriyadarsini C; Ramesh Kumar S; Terrin N; Narendran G; Menon PA; Ramachandran G; Subramanyan S; Venkatesan P; Wanke C; Swaminathan S
Clin Infect Dis; 2011 Feb; 52(4):540-6. PubMed ID: 21252141
[TBL] [Abstract][Full Text] [Related]
3. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
4. Impact of HIV infection and HAART on serum lipids in men.
Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
[TBL] [Abstract][Full Text] [Related]
5. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression.
Kanjanavanit S; Puthanakit T; Vibol U; Kosalaraksa P; Hansudewechakul R; Ngampiyasakul C; Wongsawat J; Luesomboon W; Wongsabut J; Mahanontharit A; Suwanlerk T; Saphonn V; Ananworanich J; Ruxrungtham K;
Antivir Ther; 2011; 16(8):1351-5. PubMed ID: 22155918
[TBL] [Abstract][Full Text] [Related]
7. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
8. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
[TBL] [Abstract][Full Text] [Related]
9. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
Ozder A
Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
[TBL] [Abstract][Full Text] [Related]
10. Effect of nutritional counseling on low-density lipoprotein cholesterol among Thai HIV-infected adults receiving antiretroviral therapy.
Chotivichien S; Arab L; Prasithsirikul W; Manosuthi W; Sinawat S; Detels R
AIDS Care; 2016; 28(2):257-65. PubMed ID: 26295176
[TBL] [Abstract][Full Text] [Related]
11. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
[TBL] [Abstract][Full Text] [Related]
12. First-line antiretroviral therapy and changes in lipid levels over 3 years among HIV-infected adults in Tanzania.
Liu E; Armstrong C; Spiegelman D; Chalamilla G; Njelekela M; Hawkins C; Hertzmark E; Li N; Aris E; Muhihi A; Semu H; Fawzi W
Clin Infect Dis; 2013 Jun; 56(12):1820-8. PubMed ID: 23449270
[TBL] [Abstract][Full Text] [Related]
13. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
Baker JV; Sharma S; Achhra AC; Bernardino JI; Bogner JR; Duprez D; Emery S; Gazzard B; Gordin J; Grandits G; Phillips AN; Schwarze S; Soliman EZ; Spector SA; Tambussi G; Lundgren J;
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28533305
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
[TBL] [Abstract][Full Text] [Related]
15. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
16. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study.
Wang Q; Ding H; Xu J; Geng W; Liu J; Guo X; Kang J; Li X; Jiang Y; Shang H
Lipids Health Dis; 2016 Sep; 15(1):149. PubMed ID: 27600391
[TBL] [Abstract][Full Text] [Related]
17. Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks.
Quercia R; Roberts J; Martin-Carpenter L; Zala C
Clin Drug Investig; 2015 Mar; 35(3):211-9. PubMed ID: 25637061
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of dyslipidemia in the Iraqi adult population.
Mula-Abed WA; Chilmeran SK
Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
[TBL] [Abstract][Full Text] [Related]
19. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
Quispe R; Al-Hijji M; Swiger KJ; Martin SS; Elshazly MB; Blaha MJ; Joshi PH; Blumenthal RS; Sniderman AD; Toth PP; Jones SR
J Clin Lipidol; 2015; 9(4):511-8.e1-5. PubMed ID: 26228668
[TBL] [Abstract][Full Text] [Related]
20. Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey.
Hejazi N; Rajikan R; Choong CL; Sahar S
BMC Public Health; 2013 Aug; 13():758. PubMed ID: 23947428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]